Chicoric acid prevents methotrexate-induced kidney injury by suppressing NF-κB/NLRP3 inflammasome activation and up-regulating Nrf2/ARE/HO-1 signaling

Inflamm Res. 2019 Jun;68(6):511-523. doi: 10.1007/s00011-019-01241-z. Epub 2019 Apr 29.

Abstract

Objective: Chicoric acid (CA) is a natural product with promising antioxidant and anti-inflammatory properties; however, its protective effect on methotrexate (MTX)-induced acute kidney injury (AKI) hasn't been reported. We investigated the effect of CA on MTX-induced AKI in rats, pointing to the role of NF-κB/NLRP3 inflammasome and Nrf2/ARE/HO-1 signaling.

Materials and methods: Wistar rats received 25 mg/kg and 50 mg/kg CA for 15 days and a single injection of MTX at day 16. At day 19, the rats were killed, and samples were collected for analyses.

Results: MTX induced a significant increase in serum creatinine and urea, and kidney Kim-1, reactive oxygen species (ROS), malondialdehyde and nitric oxide levels. In addition, MTX-induced rats exhibited multiple histopathological alterations, diminished antioxidant defenses, and decreased expression of Nrf2, NQO-1 and HO-1. CA prevented histological alterations, ameliorated kidney function markers, attenuated ROS production and lipid peroxidation, and boosted antioxidant defenses. CA suppressed the expression of NF-κB p65, NLRP3, caspase-1 and IL-1β in the kidney of MTX-induced rats. Furthermore, CA inhibited MTX-induced apoptosis as evidenced by the decreased expression of BAX and caspase-3, and increased Bcl-2 gene expression.

Conclusions: CA prevented MTX-induced AKI through activation of Nrf2/ARE/HO-1 signaling, and attenuation of ROS-induced activation of NF-κB/NLRP3 inflammasome signaling.

Keywords: Chicoric acid; Methotrexate; NLRP3 inflammasome; Nrf2; ROS.

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Acute Kidney Injury / drug therapy*
  • Acute Kidney Injury / immunology*
  • Acute Kidney Injury / pathology
  • Animals
  • Antioxidant Response Elements / immunology
  • Apoptosis / drug effects
  • Caffeic Acids / pharmacology*
  • Caffeic Acids / therapeutic use*
  • Folic Acid Antagonists
  • Heme Oxygenase (Decyclizing) / immunology
  • Kidney / drug effects
  • Kidney / immunology
  • Kidney / pathology
  • Male
  • Methotrexate
  • NF-E2-Related Factor 2 / immunology
  • NF-kappa B / immunology
  • NLR Family, Pyrin Domain-Containing 3 Protein / immunology
  • Rats, Wistar
  • Signal Transduction
  • Succinates / pharmacology*
  • Succinates / therapeutic use*
  • Up-Regulation / drug effects

Substances

  • Caffeic Acids
  • Folic Acid Antagonists
  • NF-E2-Related Factor 2
  • NF-kappa B
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nfe2l2 protein, rat
  • Nlrp3 protein, rat
  • Succinates
  • Heme Oxygenase (Decyclizing)
  • Hmox1 protein, rat
  • chicoric acid
  • Methotrexate